Table 3. Characterization of measles-specific humoral and cellular immunity in study subjects.
| Immune measure | Variable positive | Frequency* | Percentage* | % Cumulative | |
|---|---|---|---|---|---|
| Cellular and humoral | IgG, SI, IFN-γ, IL-4 | 127 | 37·5 | 90·2 | |
| IgG, SI, IFN-γ | 20 | 5·9 | |||
| IgG, SI, IL-4 | 21 | 6·2 | |||
| IgG, IFN-γ, IL-4 | 82 | 24·2 | |||
| SI, IFN-γ, IL-4 | 17 | 5·0 | |||
| IgG, SI | 4 | 1·2 | |||
| IFN-γ, IL-4 | 17 | 5·0 | |||
| IgG, IFN-γ | 15 | 4·4 | |||
| SI, IL-4 | 3 | 0·9 | |||
| Th1-biased | SI, IFN-γ | 2 | 0·6 | 1·2 | |
| SI | 1 | 0·3 | |||
| IFN-γ | 1 | 0·3 | |||
| Th2-biased | IgG, IL-4 | 17 | 5·0 | 7·4 | |
| IL-4 | 4 | 1·2 | |||
| IgG | 4 | 1·2 | |||
| None | – | 4 | 1·2 | 1·2 |
*
Frequency and percentage for individual immune measure are based on the cut-off criteria mentioned in the text.